Lamotrigine for cognitive deficits associated with neurofibromatosis type 1: A phase II randomized placebo-controlled trial.
Ottenhoff MJ, Mous SE, Castricum J, Rietman AB, Oostenbrink R, van der Vaart T, Tulen JHM, Parra A, Ramos FJ, Legius E, Moll HA, Elgersma Y, de Wit MY; ENCORE Expertise Center for NF1.
Ottenhoff MJ, et al. Among authors: rietman ab.
Dev Med Child Neurol. 2024 Sep 28. doi: 10.1111/dmcn.16094. Online ahead of print.
Dev Med Child Neurol. 2024.
PMID: 39340758